Hepatotoxicity induced by paroxetine [5];Hepatotoxicidad inducida por paroxetina

Medicina Clinica

Volumn 124, Issue 10, 2005, Pages 399-

  Guzmán Ruiz, Óscar ^a   Ramírez Martín Del Campo, Marte ^a   Fernandez López, Ignacio ^a   Romero Gómez, Manolo ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; INSULIN; PAROXETINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DIABETES MELLITUS; DISEASE COURSE; DRUG INDICATION; FEMALE; HUMAN; LETTER; LIVER TOXICITY;

EID: 20244370219     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13072581     Document Type: Letter

References (8)

1. a ed. Philadelphia: Panamericana, 1998, p. 1305-40.
2. Lee WM. Drug-induced hepatotoxicity. N Engl J Med. 2003;349:474-85.
3. Lanctot KL, Naranjo CA. Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events. Clin Pharmacol Ther. 1995;58:692-8.
4. De Man RA. Severe hepatitis attributed to paroxetine (Seroxat). Ned Tijdschr Geneeskd. 1997;141:540-2.
5. Cadranel JF, Di Martino V, Cazier A, Pras V, Bachmeyer C, Olympio P, et al. Atrium and paroxetine-related severe hepatitis. J Clin Gastroenterol. 1999;28:52-5.
6. Azaz-Livshits T, Hershko A, Ben-Chetrit E. Paroxetine associated hepatotoxicity: a report of 3 cases and a review of the literature. Pharmacopsychiatry. 2002;35:112-5.
7. Helmchen C, Boerner RJ, Meyendorf R, Hegerl U. Reversible hepatotoxicity of paroxetine in a patient with major depression. Pharmacopsychiatry. 1996;29:223-6.
8. Odeh M, Misselevech I, Boss JH, Oliven A. Severe hepatotoxicity with jaundice associated with paroxetine. Am J Gastroenterol. 2001;96:2494-6.